FindTrial
Sign In

Research on the Molecular Mechanism of Fibulin-1 Regulating Tumor-Associated Fibroblasts to Promote Ovarian Cancer Metastasis

Research on the Molecular Mechanism of Fibulin-1 Regulating Tumor-Associated Fibroblasts to Promote Ovarian Cancer Metastasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108402
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Ovarian cancer group:N/A

Sponsors

The First Affiliated Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Patients diagnosed with OC by pathology. 2. Age of 18 years or above. 3. Patients voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors. 2. Patients with severe heart, liver or kidney dysfunction. 3. Patients with a history of mental illness or cognitive impairment, who are unable to understand the research content and sign the informed consent form. 4. Patients participating in other clinical trials that may affect the results of this study. 5. Pregnant women or lactating women.

Design outcomes

Primary

MeasureTime frame
FBLN1;—

Countries

China

Contacts

Public ContactGuan Yutao

The First Affiliated Hospital of Ningbo University

2309732100@qq.com+86 135 6603 6278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026